Advertisement
Screener

Citadel Advisors LLC Historic Quarter Change: Foreign ADRs, New, 2023 Q2

CITADEL ADVISORS LLC historic quarter change: Foreign ADRs, New

In depositary receipts for foreign shares (depositary receipts and foreign shares traded over the counter), over 51 quarters from 2013-06-30 to 2026-03-31, CITADEL ADVISORS LLC opened 793 positions, added to 554, reduced 514 and sold out of 741.

  • Q2 2023: Stock BIOLINERX LTD; Country of operation —; Class SPONSORED ADS; Shares before 0.
  • Q2 2023: Stock MORPHOSYS AG; Country of operation —; Class SPONSORED ADS; Shares before 0.
  • Q2 2023: Stock CHIPMOS TECHNOLOGIES INC; Country of operation Taiwan; Class SPONSORD ADS NEW; Shares before 0.
  • Q2 2023: Stock YOSHITSU CO LTD; Country of operation —; Class SPONSORED ADS; Shares before 0.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1423053), 51 quarters: Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q4 2023 (2023-09-30 to 2023-12-31, filed 2024-02-14); Q3 2023 (2023-06-30 to 2023-09-30, filed 2023-11-14); Q2 2023 (2023-03-31 to 2023-06-30, filed 2023-08-14); Q1 2023 (2022-12-31 to 2023-03-31, filed 2023-05-15); Q4 2022 (2022-09-30 to 2022-12-31, filed 2023-02-14); Q3 2022 (2022-06-30 to 2022-09-30, filed 2022-11-14); Q2 2022 (2022-03-31 to 2022-06-30, filed 2022-08-15); Q1 2022 (2021-12-31 to 2022-03-31, filed 2022-05-16); Q4 2021 (2021-09-30 to 2021-12-31, filed 2022-02-14); Q3 2021 (2021-06-30 to 2021-09-30, filed 2021-11-15); Q2 2021 (2021-03-31 to 2021-06-30, filed 2021-08-16); Q1 2021 (2020-12-31 to 2021-03-31, filed 2021-05-17); Q4 2020 (2020-09-30 to 2020-12-31, filed 2021-02-16); Q3 2020 (2020-06-30 to 2020-09-30, filed 2020-11-16); Q2 2020 (2020-03-31 to 2020-06-30, filed 2020-08-14); Q1 2020 (2019-12-31 to 2020-03-31, filed 2020-05-15); Q4 2019 (2019-09-30 to 2019-12-31, filed 2020-02-14); Q3 2019 (2019-06-30 to 2019-09-30, filed 2019-11-14); Q2 2019 (2019-03-31 to 2019-06-30, filed 2019-08-14); Q1 2019 (2018-12-31 to 2019-03-31, filed 2019-05-15); Q4 2018 (2018-09-30 to 2018-12-31, filed 2019-02-14); Q3 2018 (2018-06-30 to 2018-09-30, filed 2018-11-13); Q2 2018 (2018-03-31 to 2018-06-30, filed 2018-08-10); Q1 2018 (2017-12-31 to 2018-03-31, filed 2018-05-11); Q4 2017 (2017-09-30 to 2017-12-31, filed 2018-02-09); Q3 2017 (2017-06-30 to 2017-09-30, filed 2017-11-09); Q2 2017 (2017-03-31 to 2017-06-30, filed 2017-08-11); Q1 2017 (2016-12-31 to 2017-03-31, filed 2017-05-12); Q4 2016 (2016-09-30 to 2016-12-31, filed 2017-02-10); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2009-12-31.

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q2 2023BIOLINERX LTD
CUSIP 09071M205
—SPONSORED ADS0212,769+212,769$0$339,367+$339,3672023-08-14
Q2 2023MORPHOSYS AG
CUSIP 617760202
—SPONSORED ADS034,433+34,433$0$257,215+$257,2152023-08-14
Q2 2023CHIPMOS TECHNOLOGIES INC
CUSIP 16965P202
TaiwanSPONSORD ADS NEW010,160+10,160$0$240,690+$240,6902023-08-14
Q2 2023YOSHITSU CO LTD
CUSIP 98741L101
—SPONSORED ADS071,712+71,712$0$88,206+$88,2062023-08-14
Q2 2023TDCX INC
CUSIP 87190U100
—ADS09,576+9,576$0$75,746+$75,7462023-08-14
Q2 2023MDXHEALTH SA
CUSIP 58286E102
—SPONSORED ADS021,289+21,289$0$72,595+$72,5952023-08-14
Q2 2023DBV TECHNOLOGIES S A
CUSIP 23306J101
—SPONSORED ADR028,901+28,901$0$54,912+$54,9122023-08-14
Q2 2023BEST INC
CUSIP 08653C601
—SPONSORED ADS021,843+21,843$0$46,526+$46,5262023-08-14
Q2 2023UCLOUDLINK GROUP INC
CUSIP 90354D104
Cayman IslandsSPONSORED ADS017,684+17,684$0$44,741+$44,7412023-08-14
Q2 2023TC BIOPHARM HOLDINGS PLC
CUSIP 87807D202
—SPONSORD ADS NEW075,295+75,295$0$39,989+$39,9892023-08-14
Q2 2023BANCO BRADESCO S A
CUSIP 059460402
—SPONSORED ADR010,525+10,525$0$31,680+$31,6802023-08-14
Q2 2023IHUMAN INC
CUSIP 45175B109
—ADS COMMON010,364+10,364$0$30,677+$30,6772023-08-14
Q2 2023VACCITECH PLC
CUSIP 91864C107
—ADS014,877+14,877$0$30,647+$30,6472023-08-14
Q2 2023REDHILL BIOPHARMA LTD
CUSIP 757468202
—SPON ADS NEW015,729+15,729$0$19,032+$19,0322023-08-14
Q2 2023YUNJI INC
CUSIP 98873N206
—SPON ADS011,935+11,935$0$18,857+$18,8572023-08-14
Q2 2023SAVERONE 2014 LTD
CUSIP 80516T105
—SPONSORED ADS013,438+13,438$0$18,141+$18,1412023-08-14
Q2 2023CALLIDITAS THERAPEUTICS AB
CUSIP 13124Q106
—SPONSERED ADS01,153+1,153$0$18,102+$18,1022023-08-14
Q2 2023LIXIANG ED HLDG CO LTD
CUSIP 53934A115
—SPON ADS020,853+20,853$0$11,892+$11,8922023-08-14
Q2 2023BIT MINING LIMITED
CUSIP 055474209
—SPON ADR0609+609$0$1,644+$1,6442023-08-14